Peer-reviewedLicence not statedJournal of Clinical and Experimental Hepatology5 Oct 2026

Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study

Vasileios Lekakis¹
Florence Wong²
George Papatheodoridis¹
John Vlachogiannakos¹
Evangelos Cholongitas^1,3

¹First Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, General Hospital of Athens “Laiko”, Athens, Greece
²Division of Gastroenterology and Hepatology, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada
³First Department of Internal Medicine, General Hospital of Athens “Laiko”, Medical School of National and Kapodistrian University of Athens, Athens, Greece

Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study
Faizudheen P, Deepak K Saini, Pooja Gunwal +2
Cureus19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Clinical and patient-reported predictors of days alive and out of hospital in decompensated cirrhosis
Sai Kiran Kuchana, Eric S. Orman, Kelly Mosesso +4
Hepatology communications14 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
PROMISE: a PROspective randomised double-blind parallel group placebo-controlled multicentre trial of faecal MIcrobiota tranSplantation to improve outcomEs in patients with cirrhosis over 24 months—study protocol for a clinical trial
Victoria T. Kronsten, Yevedzo Ntuli, Ellis Kobina Paintsil +181
Trials31 Jul 2026Peer-reviewedCC BY 4.0Full textClinical trials & evidence synthesisPMC
Dual-pathway targeted therapy for decompensated cirrhosis: Combined transjugular intrahepatic portosystemic shunt and cyclooxygenase-2 inhibition
Yanting Ye, Zhiyin Huang, Jinhang Gao +1
Journal of translational internal medicine24 Aug 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
Randomised, double-blind, placebo-controlled trial of faecal microbiota transplantation in patients with decompensated cirrhosis: the Livergut protocol.
Adrià Juanola, Maria José Moreta, Cristina Solé +31
BMJ open15 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref

Cite

BibTeX

@article{lekakis2026acute,
  title = {{Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study}},
  author = {Vasileios Lekakis and Florence Wong and George Papatheodoridis and John Vlachogiannakos and Evangelos Cholongitas},
  journal = {Journal of Clinical and Experimental Hepatology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jceh.2026.103686},
  url = {https://doi.org/10.1016/j.jceh.2026.103686},
}

RIS

TY  - JOUR
TI  - Acute Kidney Disease and Clinical Outcomes in Stable Outpatients With Decompensated Cirrhosis: A Prospective Cohort Study
AU  - Vasileios Lekakis
AU  - Florence Wong
AU  - George Papatheodoridis
AU  - John Vlachogiannakos
AU  - Evangelos Cholongitas
PY  - 2026
DA  - 2026/10/05
JO  - Journal of Clinical and Experimental Hepatology
DO  - 10.1016/j.jceh.2026.103686
UR  - https://doi.org/10.1016/j.jceh.2026.103686
SN  - 0973-6883
SN  - 2213-3453
ER  -

Related

Cite